| Primary |
| Premedication |
22.2% |
| Drug Use For Unknown Indication |
14.6% |
| Gastrooesophageal Reflux Disease |
8.5% |
| Product Used For Unknown Indication |
5.7% |
| Gastritis |
5.2% |
| Diffuse Large B-cell Lymphoma |
4.2% |
| Dyspepsia |
4.2% |
| Hypertension |
4.2% |
| Gastric Cancer |
3.8% |
| Abdominal Pain |
3.3% |
| Chemotherapy |
3.3% |
| Ill-defined Disorder |
3.3% |
| Prophylaxis |
3.3% |
| Duodenal Ulcer |
2.8% |
| Breast Cancer |
1.9% |
| Depression |
1.9% |
| Hyperemesis Gravidarum |
1.9% |
| Hypovitaminosis |
1.9% |
| Nausea |
1.9% |
| Ovarian Cancer |
1.9% |
|
| Drug Screen False Positive |
9.4% |
| Vomiting |
9.4% |
| Anaphylactic Shock |
7.8% |
| Drug Ineffective |
7.8% |
| Vision Blurred |
7.8% |
| Overdose |
6.3% |
| Spermatozoa Abnormal |
6.3% |
| Sepsis Neonatal |
4.7% |
| Tremor |
4.7% |
| Urticaria |
4.7% |
| Constipation |
3.1% |
| Drug Interaction |
3.1% |
| Dyspepsia |
3.1% |
| Hypersensitivity |
3.1% |
| Infection |
3.1% |
| Loss Of Consciousness |
3.1% |
| Malaise |
3.1% |
| Nausea |
3.1% |
| Rash |
3.1% |
| Rectal Haemorrhage |
3.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
51.5% |
| Product Used For Unknown Indication |
7.6% |
| Premedication |
6.6% |
| Ill-defined Disorder |
5.9% |
| Hypertension |
4.4% |
| Pain |
3.2% |
| Diabetes Mellitus |
2.2% |
| Prophylaxis |
2.2% |
| Acute Myocardial Infarction |
2.0% |
| Pruritus |
1.7% |
| Renal Transplant |
1.7% |
| B-cell Lymphoma |
1.5% |
| Ovarian Cancer |
1.5% |
| Thrombosis Prophylaxis |
1.5% |
| Infection |
1.2% |
| Poor Quality Sleep |
1.2% |
| Restlessness |
1.2% |
| Transplant Rejection |
1.2% |
| Agitation |
1.0% |
| Cardiac Disorder |
1.0% |
|
| Toxic Epidermal Necrolysis |
20.0% |
| Therapeutic Agent Toxicity |
10.0% |
| Malaise |
5.0% |
| Pyrexia |
5.0% |
| Suicide Attempt |
5.0% |
| Tremor |
5.0% |
| Urinary Tract Infection |
5.0% |
| Vomiting |
5.0% |
| Constipation |
3.3% |
| Cough |
3.3% |
| Drug Interaction |
3.3% |
| Hallucination |
3.3% |
| Multiple Drug Overdose Intentional |
3.3% |
| Pancreatitis |
3.3% |
| Renal Failure |
3.3% |
| Sedation |
3.3% |
| Syncope |
3.3% |
| Thrombocytopenia |
3.3% |
| Urticaria |
3.3% |
| Wheezing |
3.3% |
|
| Concomitant |
| Prophylaxis |
21.2% |
| Drug Use For Unknown Indication |
16.8% |
| Product Used For Unknown Indication |
7.2% |
| Dehydration |
6.0% |
| Cough |
5.7% |
| Depression |
4.8% |
| Hypertension |
4.6% |
| Rheumatoid Arthritis |
4.6% |
| Fluid Replacement |
4.5% |
| Medication Dilution |
4.4% |
| Constipation |
3.1% |
| Chemotherapy |
2.9% |
| Pain |
2.7% |
| Premedication |
2.5% |
| Therapeutic Procedure |
1.9% |
| Breast Cancer |
1.6% |
| Non-small Cell Lung Cancer |
1.6% |
| Ascites |
1.4% |
| Diabetes Mellitus |
1.3% |
| Mineral Supplementation |
1.2% |
|
| Vomiting |
11.7% |
| Sepsis |
9.3% |
| Weight Decreased |
8.4% |
| Respiratory Failure |
6.9% |
| White Blood Cell Count Decreased |
6.3% |
| Thrombocytopenia |
6.0% |
| Rash |
5.1% |
| Urticaria |
5.1% |
| Vision Blurred |
4.5% |
| Pyrexia |
4.2% |
| Tremor |
3.9% |
| Weight Increased |
3.9% |
| Syncope |
3.6% |
| Death |
3.3% |
| Hypertension |
3.0% |
| Lung Neoplasm Malignant |
3.0% |
| Nausea |
3.0% |
| Pneumonia |
3.0% |
| Somnolence |
3.0% |
| Acute Respiratory Distress Syndrome |
2.7% |
|
| Interacting |
| Depression |
50.0% |
| Irritable Bowel Syndrome |
50.0% |
|
|
